• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: JOHNSON & JOHNSON VISION CARE, INC. - US ACUVUE OASYS MULTIFOCAL LENSES, SOFT CONTACT, DAILY WEAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

JOHNSON & JOHNSON VISION CARE, INC. - US ACUVUE OASYS MULTIFOCAL LENSES, SOFT CONTACT, DAILY WEAR Back to Search Results
Catalog Number FAL
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Itching Sensation (1943); Local Reaction (2035); Red Eye(s) (2038); Eye Pain (4467)
Event Date 09/26/2021
Event Type  Injury  
Manufacturer Narrative
Product requested but not received.
 
Event Description
On (b)(6) 2021 a patient (pt) in (b)(6) sent an email to report a diagnosis of anaphylactic shock while wearing the acuvue oasys® multifocal brand contact lenses (cls). The pt reported ou discomfort approximately fours after insertion of new pair of trial lenses. On removal of the suspect ou cls, the pt experienced ou itching, redness, inflammation, throat constriction, then respiratory distress on (b)(6) 2021. The pt went to the emergency room (er) and was diagnosed with anaphylactic shock. The pt has a known latex allergy. On 06oct2021 an email was sent to the pt to advise that no latex products are included in the acuvue brand contact lenses. On 06oct2021 an email was received from the pt who will check the lens materials with the immunologist to see if any material may have possibly produced the anaphylaxis. On 06oct2021 the pts hospital discharge paperwork was received. Date of visit: (b)(6) 2021. The pt is allergic to latex, ¿caines¿ and erythromycin. The pt reported after trying multifocal contact lens, developed a facial rash, dysphonia, and difficulty breathing. The pt self-medicated with prednisone and bilidren (dehydrocholic acid) without response. The pt then presented to the er with symptoms of anaphylaxis. Adrenalin, corticoids, and antihistamines were administered. The pt was admitted to hospital for observation and management. Admitting diagnosis: anaphylactic reaction; latex allergy, chronic history summary of 24-hour clinical evolution, studies, and treatments: general tests were requested. The testing highlighted a slight alteration of creatinine that improved to normal with the use of steroids and antihistamines. The pt had a good clinical response. The pt was evaluated by the immunology team; advanced studies is agreed with tryptase, total and specific ige to latex and isac. The pt is advised to continue bilidren until outpatient follow-up for adjustment. Given the pt had a good response and the possibility of maintaining outpatient management, the patient was discharged with strict instructions. Patient condition at time of discharge ¿ improved diagnosis at time of discharge: anaphylactic reaction; chronic medical history; bariatric surgery principal diagnosis: anaphylactic shock ¿ not specified patient discharged (b)(6) 2021. Discharge instructions: relative rest, normal regimen/activities, continue chronic medications, bilidren 20mg every 12 hours by mouth, follow up with doctor or immunologist with test results that will be ready in 30 days, call with any questions, epipen prescription given if symptoms return or the patient experiences fever, intense headache, hemorrhage, or sharp pain-consult your health care provider or our emergency service. No additional medical information has been received. Latex is not used in any acuvue® brand lens materials, polypropylene blister pack, or labelling material. There is no latex in the manufacturing process or on the manufacturing equipment. Also, latex gloves are not used in manufacturing. A lot history review was performed and revealed the following: the batch record did not show any abnormalities in monomer and solution testing. All parameters tested were within specification. All sterilization requirements were successfully completed. Lot b00xhh4 was produced under normal conditions. The suspect os cls was requested for return for evaluation but it has not yet been received. This report is for the pts os. The report for the pts od will be submitted in a separate report. If any further relevant information is received, a supplemental report will be filed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand NameACUVUE OASYS MULTIFOCAL
Type of DeviceLENSES, SOFT CONTACT, DAILY WEAR
Manufacturer (Section D)
JOHNSON & JOHNSON VISION CARE, INC. - US
7500 centurion parkway
jacksonville FL 32256
Manufacturer Contact
richard holmes
7500 centurion parkway
jacksonville, FL 32256
9548020487
MDR Report Key12666171
MDR Text Key277455952
Report Number1057985-2021-00163
Device Sequence Number1
Product Code LPL
Combination Product (y/n)N
Reporter Country CodeCI
PMA/PMN Number
K200243
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 10/20/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/20/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator
Device Catalogue NumberFAL
Device Lot NumberB00XHH4
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Event Location No Information
Date Manufacturer Received10/05/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured02/22/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial

Patient Treatment Data
Date Received: 10/20/2021 Patient Sequence Number: 1
-
-